Department of Neurology, University Hospitals Leuven, Belgium (L.S., A.W., R.L.).
Department of Neurosciences, Experimental Neurology KU Leuven (L.S., A.W., R.L.), University of Leuven, Belgium.
Stroke. 2023 Jun;54(6):1560-1568. doi: 10.1161/STROKEAHA.122.041505. Epub 2023 May 9.
Reversibility of the diffusion-weighted imaging (DWI) lesion means that not all of the DWI lesion represents permanently injured tissue. We investigated DWI reversibility and the association with thrombolysis, reperfusion and functional outcome in patients from the WAKE-UP trial (Efficacy and Safety of Magnetic Resonance Imaging-Based Thrombolysis in Wake-Up Stroke).
In this retrospective analysis of WAKE-UP, a randomized controlled trial (RCT) between September 2012 and June 2017 in Belgium, Denmark, France, Germany, Spain and United Kingdom, a convolutional neural network segmented the DWI lesions (b=1000 s/mm) at baseline and follow-up (24 hours). We calculated absolute and relative DWI reversibility in 2 ways: first, a volumetric (baseline volume-24-hour volume >0) and second, a voxel-based (part of baseline lesion not overlapping with 24-hour lesion) approach. We additionally defined relative voxel-based DWI-reversibility >50% to account for coregistration inaccuracies. We calculated the odds ratio for reversibility according to treatment arm. We analyzed the association of reversibility with excellent functional outcome (modified Rankin Scale score of 0-1), in a multivariable model.
In 363 patients, the median DWI volume was 3 (1-10) mL at baseline and 6 (2-20) mL at follow-up. Volumetric DWI reversibility was present in 19% (69/363) with a median absolute reversible volume of 1 mL (0-2) or 28% (14-50) relatively. Voxel-based DWI reversibility was present in 358/363 (99%) with a median absolute volume of 1 mL (0-2), or 22% (9-38) relatively. In 18% of the patients (67/363), relative voxel-based DWI reversibility >50% was present. Volumetric DWI reversibility and relative voxel-based DWI reversibility >50% was more frequent in patients treated with alteplase versus placebo (OR, 1.86 [95% CI, 1.09-3.17] and OR, 2.03 [95% CI, 1.18-3.50], respectively). Relative voxel-based DWI reversibility >50% was associated with excellent functional outcome (OR, 2.30 [95% CI, 1.17-4.51]).
Small absolute volumes of DWI reversibility were present in a large proportion of randomized patients in the WAKE-UP trial. Reversibility was more often present after thrombolysis.
弥散加权成像(DWI)病变的可逆性意味着并非所有 DWI 病变都代表永久性损伤组织。我们研究了 WAKE-UP 试验(唤醒卒中的磁共振成像溶栓的疗效和安全性)中患者的 DWI 可逆性及其与溶栓、再灌注和功能结局的关系。
在这项 WAKE-UP 的回顾性分析中,WAKE-UP 是一项于 2012 年 9 月至 2017 年 6 月在比利时、丹麦、法国、德国、西班牙和英国进行的随机对照试验(RCT),卷积神经网络在基线和随访(24 小时)时对 DWI 病变(b=1000 s/mm)进行分段。我们以两种方式计算 DWI 的绝对和相对可逆性:首先,体积(基线体积-24 小时体积>0)和其次,体素(基线病变的一部分不与 24 小时病变重叠)方法。我们还定义了相对体素 DWI 可恢复性>50%,以弥补配准不准确的问题。我们根据治疗臂计算了可逆性的优势比。我们在多变量模型中分析了可逆性与良好功能结局(改良 Rankin 量表评分 0-1)的关系。
在 363 名患者中,基线时 DWI 体积中位数为 3(1-10)mL,随访时为 6(2-20)mL。19%(69/363)存在容积 DWI 可逆性,中位数绝对值可逆体积为 1mL(0-2)或 28%(14-50)。358/363(99%)存在基于体素的 DWI 可恢复性,中位数绝对值体积为 1mL(0-2)或 22%(9-38)。在 18%的患者(67/363)中,存在相对体素 DWI 可恢复性>50%。与安慰剂相比,接受阿替普酶治疗的患者中,容积 DWI 可逆性和相对体素 DWI 可恢复性>50%更为常见(OR,1.86 [95%CI,1.09-3.17]和 OR,2.03 [95%CI,1.18-3.50])。相对体素 DWI 可恢复性>50%与良好的功能结局相关(OR,2.30 [95%CI,1.17-4.51])。
WAKE-UP 试验中,大量随机患者存在较小的 DWI 可逆性绝对值。溶栓后更常出现可逆性。